Advertisement

Topics

Brazilian plant to make Humira biosimilar in 'tobacco-based bioreactors'

08:51 EDT 21 Jun 2017 | BioPharma-Reporter

A tobacco plant-based platform could make monoclonal antibodies up to 90% cheaper than mammalian systems, says Axis Biotec which is building a pilot plant in Brazil.

Original Article: Brazilian plant to make Humira biosimilar in 'tobacco-based bioreactors'

NEXT ARTICLE

More From BioPortfolio on "Brazilian plant to make Humira biosimilar in 'tobacco-based bioreactors'"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...